Monash IVF Group Dirección

Dirección controles de criterios 3/4

El CEO de Monash IVF Group's es Michael Knaap , nombrado en Oct 2018, tiene una permanencia de 5.5 años. compensación anual total es A$1.04M, compuesta por 54.6% salario y 45.4% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.039% de las acciones de la empresa, por valor de A$224.50K. La antigüedad media del equipo directivo y de la junta directiva es de 4.8 años y 8.7 años, respectivamente.

Información clave

Michael Knaap

Chief Executive Officer (CEO)

AU$1.0m

Compensación total

Porcentaje del salario del CEO	54.6%
Permanencia del CEO	5.6yrs
Participación del CEO	0.2%
Permanencia media de la dirección	4.8yrs
Promedio de permanencia en la Junta Directiva	8.8yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Michael Knaap en comparación con los beneficios de Monash IVF Group?
Fecha	Compensación total	Salario	Ingresos de la empresa
Dec 31 2023	n/a	n/a	AU$24m
Sep 30 2023	n/a	n/a	AU$23m
Jun 30 2023	AU$1m	AU$567k	AU$22m
Mar 31 2023	n/a	n/a	AU$19m
Dec 31 2022	n/a	n/a	AU$17m
Sep 30 2022	n/a	n/a	AU$18m
Jun 30 2022	AU$794k	AU$552k	AU$18m
Mar 31 2022	n/a	n/a	AU$21m
Dec 31 2021	n/a	n/a	AU$23m
Sep 30 2021	n/a	n/a	AU$24m
Jun 30 2021	AU$908k	AU$501k	AU$25m
Mar 31 2021	n/a	n/a	AU$22m
Dec 31 2020	n/a	n/a	AU$18m
Sep 30 2020	n/a	n/a	AU$15m
Jun 30 2020	AU$561k	AU$479k	AU$12m
Mar 31 2020	n/a	n/a	AU$15m
Dec 31 2019	n/a	n/a	AU$18m
Sep 30 2019	n/a	n/a	AU$19m
Jun 30 2019	AU$520k	AU$402k	AU$20m
Mar 31 2019	n/a	n/a	AU$19m
Dec 31 2018	n/a	n/a	AU$19m
Sep 30 2018	n/a	n/a	AU$20m
Jun 30 2018	AU$424k	AU$350k	AU$21m
Mar 31 2018	n/a	n/a	AU$24m
Dec 31 2017	n/a	n/a	AU$26m
Sep 30 2017	n/a	n/a	AU$28m
Jun 30 2017	AU$466k	AU$340k	AU$30m

Compensación vs. Mercado: La compensación total ($USD669.81K) de Michael está en línea con el promedio de empresas de tamaño similar en el mercado Australian ($USD769.02K).

Compensación vs. Ingresos: La compensación de Michael ha aumentado más de un 20% en el último año.

CEO

Michael Knaap

5.6yrs

Permanencia

AU$1,038,539

Compensación

Mr. Michael D. Knaap serves as Chief Executive Officer, Managing Director and Executive Director of Monash IVF Group Limited since April 15, 2019. Mr. Knaap served as an Interim Chief Executive Officer of...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Michael Knaap	CEO, MD & Executive Director	5.6yrs	AU$1.04m	0.19% A$ 1.1m
Malik Jainudeen	Group CFO & Company Secretary	5.1yrs	AU$511.77k	0.0049% A$ 28.8k
Hamish Hamilton	Chief Operating Officer	4.2yrs	AU$504.44k	0.032% A$ 185.1k
Richard Henshaw	Executive Director	10.1yrs	AU$343.97k	0.35% A$ 2.0m
Deirdre Zander-Fox	Chief Scientific Officer	no data	sin datos	sin datos
Thierry Panthier	Chief Information Officer	2.3yrs	sin datos	sin datos
Fiona Allen	Chief Marketing Officer	4.8yrs	sin datos	sin datos
Peggy North	Chief People & Culture Officer	no data	sin datos	sin datos
Tedd Fuell	Chief Governance & Risk Officer	no data	sin datos	sin datos
Johannes Lagerwij	Managing Director of Asia	1.3yrs	sin datos	sin datos

4.8yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de MVF se considera experimentado (4.8 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Michael Knaap	CEO, MD & Executive Director	5.1yrs	AU$1.04m	0.19% A$ 1.1m
Richard Henshaw	Executive Director	10.1yrs	AU$343.97k	0.35% A$ 2.0m
Neil Broekhuizen	Independent Non-Executive Director	9.9yrs	AU$102.53k	0.090% A$ 523.3k
Josef Czyzewski	Independent Non-Executive Director	9.9yrs	AU$120.36k	0.062% A$ 360.9k
Richard Davis	Independent Non-Executive Chairman	9.9yrs	AU$168.27k	0.047% A$ 272.2k
Zita Peach	Independent Non-Executive Director	7.6yrs	AU$111.46k	0.024% A$ 138.8k
Catherine West	Independent Non-Executive Director	3.7yrs	AU$102.53k	0.0095% A$ 55.5k
Catherine Aston	Independent Non-Executive Director	less than a year	sin datos	sin datos

8.8yrs

Permanencia media

63.5yo

Promedio de edad

Junta con experiencia: La junta directiva de MVF se considera experimentada (8.7 años de antigüedad promedio).

Monash IVF Group Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

Insufficient new directors

Monash IVF Group Limited, Annual General Meeting, Nov 11, 2022

Insufficient new directors

Insufficient new directors

Independent Non-Executive Director recently bought AU$192k worth of stock

Recent updates

Monash IVF Group Limited (ASX:MVF)completed the acquisition of 80% stake in Fertility North Holdings Pty Ltd.

Upcoming dividend of AU$0.025 per share

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.027 in 1H 2023)

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

First half dividend of AU$0.025 announced

Monash IVF Group Limited to Report First Half, 2024 Results on Feb 23, 2024

Upcoming dividend of AU$0.022 per share at 3.5% yield

Monash IVF Group Limited Announces Fully Franked Final Dividend for Fiscal Year Ended June 30, 2023, Payable on 11 October 2023

Full year 2023 earnings released: EPS: AU$0.056 (vs AU$0.047 in FY 2022)

Monash IVF Group Limited Provides Update on Class Action Lawsuit

Monash IVF Group Limited (ASX:MVF) completed the acquisition of PIVET Medical Centre.

Upcoming dividend of AU$0.022 per share at 4.2% yield

First half 2023 earnings released: EPS: AU$0.027 (vs AU$0.031 in 1H 2022)

Monash IVF Group Limited to Report First Half, 2023 Results on Feb 21, 2023

Insufficient new directors

Monash IVF Group Limited (ASX:MVF) completed the acquisition of ART Associates Queensland #2 Pty Ltd.

Upcoming dividend of AU$0.022 per share

Full year 2022 earnings released: EPS: AU$0.047 (vs AU$0.065 in FY 2021)

Monash IVF Group Limited Announces Ordinary Fully Paid Distribution for the Six Months Ended June 30, 2022, Payable on October 7, 2022

Monash IVF Group Limited to Report Fiscal Year 2022 Results on Aug 26, 2022

Monash IVF Group Limited, Annual General Meeting, Nov 11, 2022

Insufficient new directors

Monash IVF Group Limited (ASX:MVF) agreed to acquire PIVET Medical Centre for AUD 9.4 million.

Insufficient new directors

Monash IVF Group Limited Announces Fully Franked Distribution for the Six Months That Ended December 31, 2021, Payable on April 4, 2022

Monash IVF Group Limited to Report First Half, 2022 Results on Feb 17, 2022

Monash IVF Group Limited Updates Temporary Suspension of IVF Procedures Lifted in Victoria

Upcoming dividend of AU$0.021 per share

Full year 2021 earnings released: EPS AU$0.065 (vs AU$0.046 in FY 2020)

Independent Non-Executive Director recently bought AU$192k worth of stock

New 90-day low: AU$0.70

Revenue beats expectations

First half 2021 earnings released: EPS AU$0.037 (vs AU$0.035 in 1H 2020)

New 90-day high: AU$0.80

New 90-day high: AU$0.72

New 90-day high: AU$0.65

Monash IVF Group Limited Provides Earnings Guidance for the Second Half and Full Year of the Fiscal Year 2020

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Miembros de la Junta

Permanencia media

Promedio de edad